The global veterinary biologics market is poised for significant growth, with its valuation expected to increase from USD 13,140.6 million in 2024 to USD 24,224.3 million by 2034, registering a compound annual growth rate (CAGR) of 6.3% over the forecast period. This expansion reflects rising demand for advanced animal healthcare solutions, driven by increased pet ownership, growing awareness of zoonotic diseases, and advancements in biotechnology.
Key Market Drivers
- Rising Pet Ownership and Livestock Care: The growing trend of pet humanization and increasing focus on livestock health are driving the adoption of veterinary biologics, which are essential for disease prevention and treatment in animals.
- Growing Awareness of Zoonotic Diseases: Heightened awareness of diseases transmitted between animals and humans is emphasizing the need for effective vaccination and biologics to maintain public health.
- Advancements in Biotechnology: Innovations in biotechnology, including recombinant DNA technology and monoclonal antibodies, are enabling the development of more effective and targeted veterinary biologics.
Market Trends and Opportunities
- Increased Adoption of Vaccines: Veterinary vaccines, a key segment in the biologics market, are gaining traction due to their role in preventing infectious diseases in both companion and livestock animals.
- Focus on Regional Livestock Health: Emerging economies are increasing investments in animal healthcare infrastructure to support livestock health and productivity, boosting demand for veterinary biologics.
- Development of Targeted Therapies: Advancements in precision medicine are paving the way for biologics tailored to specific animal species and diseases, enhancing treatment outcomes.
Future Outlook
As awareness of animal health and its implications on public safety continues to grow, the veterinary biologics market is expected to see sustained growth. Investments in research and development, along with increasing access to veterinary care in emerging markets, will further bolster market expansion over the next decade.
A Full Report Analysis – https://www.futuremarketinsights.com/reports/veterinary-biologics-market
Key Takeaways:
- The global veterinary biologics market is projected to grow from USD 13,140.6 million in 2024 to USD 24,224.3 million by 2034, at a CAGR of 6.3%.
- Rising pet ownership, zoonotic disease awareness, and advancements in biotechnology are key market drivers.
- Veterinary vaccines are a major contributor to the market, addressing the need for disease prevention in animals.
- Emerging economies and tailored biologics solutions present significant growth opportunities for market players.
Growth Drivers
- Increasing Demand for Animal Health Products:
- The rising awareness of animal health and welfare is driving the demand for effective veterinary biologics, including vaccines and diagnostic kits, which are essential for preventing disease outbreaks.
- Food Security Initiatives:
- Global initiatives aimed at ensuring food security through improved livestock health are propelling the market for veterinary biologics, as healthy animals contribute to better food production.
- Regulatory Support:
- Government regulations promoting animal health and welfare are facilitating the growth of the veterinary biologics market by encouraging vaccination and disease prevention measures.
- Technological Advancements:
- Innovations in vaccine development and production processes are enhancing the efficacy and availability of veterinary biologics, making them more appealing to veterinarians and pet owners alike.
- Growing Pet Ownership:
- The increasing trend of pet ownership, particularly in urban areas, is leading to a higher demand for preventive healthcare measures, including vaccines and biologics.
Key Veterinary Biologics Market Players
- Elanco Animal Health
- Ceva
- Phibro Animal Health Corporation
- Boehringer Ingelheim
- Zoetis Inc.
- Merck & Co. Inc.
- Virbac
- Hester Biosciences Limited
- Colorado Serum Company
- Addison Biological Laboratory Inc.
- American Animal Health Inc.
- HIPRA
- Bimeda Inc. (Texas Vet Lab Inc.)
Key Segments in the Veterinary Biologics Market Report
By Product:
- Vaccines
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Bacterial Extracts
- Monoclonal Antibody
- Immunomodulatory
- Cytokines
- Others
- Allergenic Extracts
By Animal:
- Companion Animals
- Canine
- Avian
- Feline
- Livestock
- Aquatic
- Bovine
- Porcine
- Ovine/Caprine
- Poultry
- Equine
By Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
